Current Status

Not Enrolled

Price

Free

Get Started

A new paper published in the February 2024 edition of the American Journal of Obstetrics & Gynecology outlines new practice guidelines for omega-3 DHA and preterm birth. In this course, we will discuss how doctors can use these guidelines to advise patients on optimal DHA intake during pregnancy.

Course Overview:

  • Why DHA is so important for women before, during and after pregnancy
  • New practice guidelines for doctors advising patients about omega-3 DHA intake during pregnancy
  • Which types of individuals will benefit most from adding DHA to their prenatal nutrition routine
  • Why testing your patients’ DHA status matters

 

Course Leader:

Kristina Harris Jackson, PhD, RD, Director of Research, OmegaQuant

Kristina Harris Jackson, PhD, RD, is the Director of Research for OmegaQuant Analytics, LLC, and an Assistant Professor (non-tenure) in the Department of Internal Medicine at the University of South Dakota Sanford School of Medicine. Kristina received her PhD in Nutritional Sciences from Pennsylvania State University in 2013 and completed her training to become a Registered Dietitian in 2014. Kristina continues her research in the area of omega-3s in maternal health, helping create the Prenatal DHA test and the Mother’s Milk DHA test, and continues her clinical work by consulting with clients on their lab values from OmegaQuant. Kristina lives in Sioux Falls, South Dakota with her partner and two kids.

Course Content

Video Lesson: Clinical Guidelines for DHA & Preterm Birth

These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.